Previously, we have shown that protein kinase C (PKC) and NO pathways are altered in aortic rings of LPS-treated rats and chelerythrine (a potent PKC inhibitor) pretreatment was able to significantly improve the LPS-induced endothelial dysfunction (13). This evidence concerns the gene PRRT2 and endothelial dysfunction.